Korean Linguistic Adaptation of Rhinitis Controlled Assessment Test
R-CAT
Linguistic Adaptation of Rhinitis Control Assessment Test (RCAT) in Korean and Responsiveness to Disease Severity, Quality of Life, and Treatment in Adult Rhinitis Patients: A Multicenter Prospective Study
1 other identifier
observational
130
1 country
1
Brief Summary
Korean linguistic adaptation of Rhinitis controlled assessment test (RCAT).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2014
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2014
CompletedFirst Submitted
Initial submission to the registry
October 17, 2014
CompletedFirst Posted
Study publicly available on registry
October 31, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2015
CompletedMay 2, 2016
April 1, 2016
11 months
October 17, 2014
April 28, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Korean linguistic adaptation of Rhinitis controlled assessment test (RCAT)
Check the Korean version of rhinitis controlled assessment tests
up to 4weeks
Secondary Outcomes (1)
rhinitis-related quality of life
up to 4weeks
Interventions
Check the Korean version of rhinitis controlled assessment tests, the total non-symptom scores (total nasal symptoms score, TNSS), rhinitis-related quality of life (RQLQ), rhinitis controlled degree, severity, and after study enrollment and 4 weeks treatment.
Eligibility Criteria
rhinitis within 12 months from the time of study enrollment.
You may qualify if:
- Adults over 19 years
- Past medical history and allergy skin test or who have been diagnosed with allergic or non-allergic rhinitis, based on serum specific immunoglobulin E .
- People who have experienced symptoms of rhinitis within 12 months from the time of study enrollment.
- People who have rhinitis symptoms requiring medication at the time of study enrollment.
- People who can read and write korea language.
- People who signed a written consent form approved by the Institutional Review Board of their respective organizations to participate in this study freely hearing to explain fully the purpose for the contents of this study prior to participation in research.
You may not qualify if:
- People diagnosed with Rhinitis medicamentosa.
- People determined that bacterial or viral respiratory infection at the time of study enrollment.
- People who have evidence of nasal infection
- People associated anatomical abnormality that causes severe nasal congestion as deviation of nasal septum.
- People determined that acute or chronic sinusitis according to the researchers determined.
- In case that pregnancy test is positive, or ambiguous conclusions among female patients.
- people deemed unsuitable for clinical trial participation due to other reasons.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ajou University Medical Center
Suwon, South Korea
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
hae sim park, professor
Department of internal medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor, Department of allergic interal medicine
Study Record Dates
First Submitted
October 17, 2014
First Posted
October 31, 2014
Study Start
October 1, 2014
Primary Completion
September 1, 2015
Study Completion
October 1, 2015
Last Updated
May 2, 2016
Record last verified: 2016-04